Showing 121 - 140 results of 29,102 for search '(( e non decrease ) OR ( 5 ((((ng decrease) OR (mean decrease))) OR (teer decrease)) ))', query time: 0.91s Refine Results
  1. 121
  2. 122
  3. 123

    HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

    Published 2015
    “…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”
  4. 124
  5. 125
  6. 126

    Antagonizing BMP type I receptors decreases cell growth, proliferation, and clonogenicity of lung cancer cell lines. by Elaine Langenfeld (402034)

    Published 2013
    “…<p>(<b>A</b>) A549 and H1299 cells cultured in DMEM 5% FCS were treated with DMSO, 10 µM Dorsomorphin, 1 µM DMH1, 1 µM DMH2, or 1 µM LDN for 7 days and cell counts performed. …”
  7. 127
  8. 128
  9. 129
  10. 130

    (R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

    Published 2011
    “…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”
  11. 131
  12. 132
  13. 133
  14. 134
  15. 135
  16. 136
  17. 137

    Hematopoietic potential decreases in ESC with down-regulation of junction molecules. by Basha L. Stankovich (207031)

    Published 2011
    “…CD45 expression was analyzed flow cytometrically using anti-CD45 conjugated to PerCP-Cy5.5. Non-viable cells were excluded based on DAPI fluorescence. …”
  18. 138
  19. 139
  20. 140